Influenza Vaccine in Elderly Adults: Is High-Dose Better Than Standard-Dose?
A higher dose of the flu vaccine provided better protection against respiratory and all-cause hospital admissions.
All articles by Cindy Lampner, MSLIS
Time to Sputum Culture Conversion Similar in Isoniazid-Resistant and Susceptible TB
A new study examined whether isoniazid resistance was associated with variations in treatment outcomes in patients receiving standard first-line pharmacotherapy for TB.
Influenza Vaccination During Pregnancy Reduces Infant Risk for Acute Lower Respiratory Infection
Influenza vaccination during pregnancy decreases infant hospitalizations for all-cause acute lower respiratory tract infection during the first 3 months of life.
Meningococcal B Vaccine Protective Against Gonorrhea
People who had been vaccinated with the MeNZB vaccine were less likely to have gonorrhea than people who weren’t vaccinated.
No Benefits Seen for Adjunctive Clindamycin in Cellulitis
Results from atrial of clindamycin in cellulitis cast doubt on hospital guidelines.
Sepsis-Related Mortality Decreased With Rapid Implementation of Protocol
Rapid treatment of sepsis using mandated care bundles improves outcomes.
No Elevated Malformations Risk, Low Birth Weight With Maternal Dengue
Epidemiological study finds reassuring outcomes for Brazilian babies born to mothers with symptomatic dengue during pregnancy.
Preadmission Corticosteroids Lower ARDS Risk in Patients With Sepsis
Retrospective study analyzes whether preadmission oral corticosteroids might lower ARDS risk in patients admitted to the ICU.
Ridinilazole Beats Standard of Care in Phase 2 C difficile Study
Recurrent Clostridium difficile infection is associated with a significant economic and mortality burden, but new treatment shows promise.
Novel Adjuvanted H7N1 Vaccine Safe, Immunogenic in Older Adults
The adjuvanted H7N1 vaccine was safe and immunogenic after 2 doses in adults age 65 and older, according to a new study.
Next post in Influenza
